9
Views
0
CrossRef citations to date
0
Altmetric
Review

Molecular genetics of ADHD: prospects for novel therapies

Pages 491-497 | Published online: 10 Jan 2014

References

  • The MTA Co-operative Group. A 14-month randomized clinical trial of treatment strategies for Attention-Deficit/ Hyperactivity Disorder. Arch. Gen. Bychiatry56, 1073–1086 (1999).
  • Levy F, Hay DA, McStephen M, Wood C, Waldman I. ADHD: A category or a continuum? Genetic analysis of a large-scale twin study. jAm Acad. Child Adolesc. fiychiatry36(6), 737–744 (1997).
  • ••A key paper showing high heritabilityacross the whole range of DSMIII-R-ADHD symptomatology, whether considered as a category or a continuum. DSM-1V subtypes may be more complicated.
  • SOian40 MV, Arnsten AFT, Castellanos FX. The neuroscience of stimulant drug action. SIn: Stimulant Drugs ancl ADHD. Basic and Clinical Neuroscience. olanto, MV, Arnsten AFT, Castellanos FX (Eds). Oxford University Press Publishers, Oxford, UK, 355–379 (2001).
  • Levy E The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust. NZI. Bychiatry25, 277–283 (1991).
  • Castellanos FX. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin. Paediab: 36,381–393 (1997).
  • •A useful statement of the dopamine theory
  • Seeman P, Madras BK. Antihyperactivity medication: methylphenidate and amphetamine. Mal Bychiatry 3,386–396 (1999).
  • O'Donnell P, Grace AA. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J. Neurosci. 15(5 Pt 1), 3622–3639 (1995).
  • Grace AA. The tonic/phasic model of dopamine system regulation; its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug- Ak. Depend. 37,111–729 (1995).
  • •An important theory of synaptic dopamine mechanisms in ADHD.
  • Grace AA. Psychostimulant actions on dopamine and limbic system function: Relevance to the pathophysiology and treatment of ADHD In: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. Solanto MV, Arnsten AFT, Castellanos FX. (Eds), Oxford University Press Publishers, Oxford, UK, 134–157 (2001).
  • Krause K-H, Dresel SH, Krause J, Kung HF, Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder; effects of methylphenidate as measured by single photon emission computed tomography. Neurosci. Let. 285, 107–110 (2000).
  • Volkow ND, Wang G J, Gatley SJ et al Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry 155,1325–1331 (1998).
  • ••The dopamine transporter is an importantregulator of synaptic dopamine activity
  • Amsten AFT Catecholamine modulation of prefrontal cortical cognitive function. Tends Cog. Sci. 2,436–447 (1998).
  • Arnsten A, Steere JC, Hunt RD. The contribution of alpha sub2-noradrenergic mechanisms to prefrontal cortical cognitive function: Potential significance for Attention-Deficit Hyperactivity Disorder. Atrh. Gen. Psych/at. 53,448-455 (1996).
  • Amsten AFT, Steere JC, Jentsch DJ, Li BM. Noradrenergic influences on prefrontal cortical cognitive function: Opposing actions at postjunctional alpha1 versus alpha2- adrenergic receptors. Adv. Pharmacol 42,764–767 (1998).
  • Amsten AFT. Dopamineric and noradrenergic influences on cognitive functions mediated by the prefrontal cortex. In: Stimulant Drugs ancl ADHD. Bask and Clinical Neuroscience. Oxford University Press, Oxford, UK, 185–208 (2001).
  • Jakala P, Rieckkinen M, Siervio J et al Guanfacine but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacol 20,460–470 (1999).
  • McGuffin P, Riley B, Plomin R. Genomics and behavior: Toward behavioural genomics. Science 291,1232–1249 (2001).
  • Asherson PJ, Curran S. Approaches to gene mapping in complex disorders and their application in child psychiatry and psychology. Br. PTchiatry 179,122–128 (2001).
  • Baron M. The search for complex disease genes: fault by linkage or fault by association? Md. Psychiatry 6, 143–149 (2001).
  • Cook EH, Stein MA, Krasowski MD, Cox NJ, Olken DM Keiffer JE. Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56, 993–998 (1995).
  • •This was the first report on the association of the dopamine transporte gene and ADHD.
  • La Hoste GJ, Swanson JM, Wigal SB etal Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatryl, 121–124 (1996).
  • ••This was the first report on the associationof the Dopamine D4 receptor gene and ADHD.
  • Barr CL, Wigg KL, Feng Y et al Attention-deficit disorder and the gene for the dopamine D5 receptor. Mal Bychiatry5, 548–551 (2000).
  • Rowe DC, Stever C, Sherman S, Abramowitz, Waldman ID. Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms. Mal Psychiatry 6,429–433 (2001).
  • Swanson JM, Flodman P, Kennedy J et al Dopamine genes and ADHD. Neurosci. Biobehav. Rev 24,21–25 (2000).
  • Swanson J, Posner M, Fusella J etal Genes and attention deficit hyperactivity disorder. CL117: Psychiatry Rep. 3,92-100 (2001).
  • Swanson J, Oosterlaan J, Murias M etal Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc. Natl Acad. Li. USA 97(9), 4754–4759 (2000).
  • Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine d(4) receptor gene and attention deficit hyperactivity disorder. Am. J. Rychiatry 158(7), 1052–1057 (2001).
  • Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit disorder and the dopamine transporter polymorphism. Mal Psychiatry2, 311–313 (1997).
  • •• This meta-analysis establishes the small but significant association of the Dopamine D4 receptor gene with ADHD.
  • Waldman ID, Rowe DC, Abramowitz A etal Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Arn. J. Human Genet. 63, 1767–1776 (1998).
  • Daly G, Hawi Z, Fitzgerald M etal. Mapping susceptibility loci attention-deficit/hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. P9rhiatry 4,192–196 (1999).
  • Asherson P, Virdee V, Curran S etal Association study of DSM-IV attention-deficit/hyperactivity disorder (ADHD) and monoamine pathway genes. Am. J. Med. Genet. Veuropsychiatr Genet) 81,548 (1998).
  • Palmer CGS, Bailey JN, Ramsey C etal No evidence of linkage or linkage disequilibrium between DAT1 and attention-deficit/hyperactivity disorder in a large sample. Bychiatr Genet. 9,157–160 (1999).
  • Payton A, Holmes, Barrett JH eta]. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am. J. Med. Genet. Neuropsych. Genet.) 105,464–470 (2001).
  • Mill JS, Caspi A, McClay J etal The dopamine D4 receptor and the hyperactivity phenotype: A developmental-epidemiological study. Ma/ PTchiatry7(4), 383–391 (2002).
  • •This is a useful review of current molecular genetic DRD4 studies.
  • Swanson JM, Sunahara GA, Kennedy JL etal Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): A family-based approach. Mol. PFhiatry 3,38–41 (1998).
  • Rowe MI, Stever C, Giedinghaven LN etal Dopamine DRD4 receptor polymorphism and attention deficit disorder. Mol. P9rhiatry3, 419–426 (1998).
  • Smalley SL, Bailey JN, Palmer CG etal Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol. Rychiatry3, 427–430 (1998).
  • Curran S, Mill J, Sham P et al QTL association analysis of the DRD4 exon 3 VNTR polymorphism in a population sample of children screened with a parent rating scale for ADHD symptoms. Am. J. Med. Genet. 105,387-393 (2001).
  • Faraone SV, Biederman J, Weiffenbach B etal Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am.Bychiatry 156(5), 768–770 (1999).
  • Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson PJ. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol. PFhiatry 5 (4), 396–404 (2000) .
  • Muglia P, Jam U, Macciardi F, Kennedy JL. Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am. J. Med. Genet. 96(3), 273–277 (2000).
  • Sunahara GA, Roberts W, Malone M etal Linkage of the dopamine D4 receptor gene and attention-deficit/hyperactivity disorder. Am. Acad. Child Adolesc. Bychiatry 39(12), 1537–1542 (2000).
  • Holmes J, Payton A, Barrett JH etal A family-based and case control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol. Psychiatry5(5), 523–530 (2000).
  • Mill J, Curran S, Kent etal Attention deficit hyperactivity disorder (ADHD) and the dopamine D4 receptor gene: evidence of association but no linkage in a UK sample. Mol. Psychiatry 6(4), 440–444 (2001).
  • Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MET. Attention-deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am. J. Med. Genet 105(5), 471–478 (2001).
  • Castellanos FX, Lau E, Tayebi N etal Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: genetic and brain morphometric analyses. Mol. Psychiatry3, 431–434 (1998).
  • Hawi Z, McCarron M, Kirley A, Daly G, Fitzgerald M, Gill M. No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am.j Med. Genet 96(3), 268–272 (2000).
  • Eisenberg J, Zohar A, Mei-Tal G eta]. A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). Am. J. Med. Genet. 96(3), 258–261 (2000).
  • Kotler M, Manor I, Sever Y etal. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am. J. Med. Genet. 96(3), 278–281 (2000).
  • Payton A, Holmes J, Barrett JH etal Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: A family-based study. Am. Med Genet. 105(5), 464–470 (2001).
  • Todd RD, Neuman RJ, Lobos EA, Jong YJ, Reich W Heath AC. Lack of association of dopamine D4 receptor gene polymorphisms with ADHD subtypes in a population sample of twins. Am. J. Med. Genet. 105(5), 432–438 (2001).
  • McCracken JT, Smalley SL, McGough JJ, etal Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD) . Mol. P9rhiatry5 (5), 531–536 (2000).
  • Barr CL, Feng Y, Wigg KG etal 5' Untranslated region of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Arn. J. Med. Genet. 105,84-90 (2001).
  • Lakatos K, Nemoda Z, Toth I etal Further evidence for the role of the dopamine D4 receptor (DRD4) gene in attachment disorganization: interaction of the exon III 48-bp repeat and the -521 C/T promoter polymorphisms. Mol. Bychiatry 7,27–31 (2002).
  • Ebstein RP, Novick 0, Umansky R etal Dopamine D4 receptor (DRD4) exon III polymorphism associated with the human personality trait of novelty seeking. Nat. Genet. 12,78-80 (1996).
  • ••This is the first association of a personalitytrait with a gene.
  • Benjamin J, Li L, Patterson C eta]. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat. Genet.12, 81–84 (1996).
  • Benjamin J, Ebstein RP, Lesch K-P. Genes for personality traits: implications for psychopathology. Int. J. Neuropsychopharm. 1,153-168 (1998).
  • Barr CL, Wigg K, Zai J etal Attention-deficit hyperactivity disorder and the adrenergic receptors a 1C and a 2C. Mal Psychiatry 6,334–337 (2001).
  • Kent L, Green E, Holmes J etal No association between CHRNA7 microsattelite markers and attention-deficit hyperactivity disorder. Am. J. Med. Genet. Neuropsych. Genet.), 105,686-689 (2001).
  • Grigorenko EL, Wood FB, Meyer MS etal Susceptibility loci for distinct components of developemental dyslexia on chromosomes 6 and 15. Am. J. Human Genet. 60,27-39 (1997).
  • Morris DW, Robinson L, Turic D eta]. Family-based association mapping provides evidence for reading disability on chromosome 15q. Hum. Mal Genet. 9, 843–848 (2000).
  • Schulte-Korne G, Grimm T, Nothen MM, Muller-Myhsok B, Propping P, Remschmidt H. Evidence for linkage of spelling disability to chromosome 15. Am. J. Med. Genet. Neuropsych. Genet. 74,661 (1997).
  • Grigorenko EL. Developemental dyslexia: An update on genes, brains and environments. J. Child Psychol. Psychiatry 1,
  • –125 (2001).
  • • An excellent review of the genetics of dyslexia.
  • Alarcon M and DeFries JC. Reading performance and general cognitive ability in twins with reading difficulties and control pairs. Personality Indiv. Diff. 22, 793–803 (1997).
  • Cardon LR, Smith SD, Fulker DW, Kimberling WJ, Pennington BF, DeFries JC. Quantitive trait locus for reading disability on chromosome 6. Science 266, 276–279 (1994).
  • Stevenson J. Comorbidity of reading/ spelling disability and ADHD. In: Attention, Genes and ADHD. Levy F, Hay D (Eds), Brunner-Routledge, Hove, East Sussex, UK, 99–114 (2001).
  • Winsberg BG, Commings DE. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J. Am. Acad. Child Adolesc. Psychiatry 38, 1474–1477 (1999).
  • •• The first pharmacogenomic study in child psychiatry.
  • Seeger G, Schloss P, Schmidt MH. Marker gene polymorphisms in hyperkinetic disorder - predictors of clinical response to treatment with methylphenidate? Neurosci. Lett. 313, 45–48 (2001).
  • Greenwood TA, Alexander M, Keck PE et al. Segmental linkage disequilibrium within the dopamine transporter gene. Mol. Psychiatry 7, 165–173 (2002)
  • Rasmussen ER, Neuman RJ, Heath AC, Levy F, Hay DA, Todd RJ. Replication of the latent class structure of attentiondeficit/ hyperactivity disorder (ADHD) in a sample of Australian twins. J. Child Psychol. Psychiatry (In press).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.